Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo.
about
Recent progress in the development of polysaccharide conjugates of docetaxel and paclitaxelFabricated ElastinFormulation and characterisation of magnetic resonance imageable thermally sensitive liposomes for use with magnetic resonance-guided high intensity focused ultrasoundUltrasound-enhanced tumor targeting of polymeric micellar drug carriers.Preparation of dendritic graft copolymer consisting of poly-(L-lysine) and arabinogalactan as a hepatocyte specific DNA carrier.Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers.Two-step fluorescence screening of CD21-binding peptides with one-bead one-compound library and investigation of binding properties of N-(2-hydroxypropyl)methacrylamide copolymer-peptide conjugatesPhase I study of CT-2103, a polymer-conjugated paclitaxel, and carboplatin in patients with advanced solid tumors.Emerging PEGylated drugs.Pharmacokinetics and tissue distribution of PGG-paclitaxel, a novel macromolecular formulation of paclitaxel, in nu/nu mice bearing NCI-460 lung cancer xenograftsHPMA copolymers: origins, early developments, present, and future.Polymerizable Fab' antibody fragments for targeting of anticancer drugs.A single dose of doxorubicin-functionalized bow-tie dendrimer cures mice bearing C-26 colon carcinomas.A highly tumor-targeted nanoparticle of podophyllotoxin penetrated tumor core and regressed multidrug resistant tumors.A systemic route for drug loading to lymphatic phagocytesConstruction of paclitaxel-loaded poly (2-hydroxyethyl methacrylate)-g-poly (lactide)-1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine copolymer nanoparticle delivery system and evaluation of its anticancer activity.Augmentation of tumour delivery of macromolecular drugs with reduced bone marrow delivery by elevating blood pressure.Hepatic arterial chemotherapy for metastatic colorectal carcinoma.Thermal targeting of an acid-sensitive doxorubicin conjugate of elastin-like polypeptide enhances the therapeutic efficacy compared with the parent compound in vivo.Anthracycline antibiotics non-covalently incorporated into the block copolymer micelles: in vivo evaluation of anti-cancer activity.Targeting of multidrug-resistant human ovarian carcinoma cells with anti-P-glycoprotein antibody conjugates.Targeted drug delivery in cancer therapy.Multifunctional synthetic poly(L-glutamic acid)-based cancer therapeutic and imaging agents.Chemotherapeutic evaluation of a synthetic tubulysin analogue-dendrimer conjugate in c26 tumor bearing miceAntibody-cytotoxic agent conjugates for cancer therapy.Anticancer activity of proapoptotic peptides is highly improved by thermal targeting using elastin-like polypeptides.Odyssey of a cancer nanoparticle: from injection site to site of action.A thermally targeted c-Myc inhibitory polypeptide inhibits breast tumor growth.Metronomic activity of CD44-targeted hyaluronic acid-paclitaxel in ovarian carcinoma.Noninvasive visualization of in vivo drug delivery of poly(L-glutamic acid) using contrast-enhanced MRI.Development of octreotide-conjugated polymeric prodrug of bufalin for targeted delivery to somatostatin receptor 2 overexpressing breast cancer in vitro and in vivo.An insight on hyaluronic acid in drug targeting and drug delivery.Design, synthesis and applications of hyaluronic acid-paclitaxel bioconjugates.Combination chemotherapy and photodynamic therapy with fab' fragment targeted HPMA copolymer conjugates in human ovarian carcinoma cellsTumour and dendrimers: a review on drug delivery aspects.Gonadotropin-releasing hormone analogue conjugates with strong selective antitumor activity.Anticancer therapeutics: targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor.Self-assembly of thermally responsive nanoparticles of a genetically encoded peptide polymer by drug conjugationHPMA copolymer-doxorubicin-gadolinium conjugates: synthesis, characterization, and in vitro evaluationPeptide-based Biopolymers in Biomedicine and Biotechnology.
P2860
Q27010654-053384BC-6343-44B4-90C0-0AF7F0C4C9D2Q28087162-27973313-1863-40BF-B8BE-D3A15A122919Q30464743-FE0FFC17-ADE2-44B3-AE29-D6BF1FA8AEA7Q30539749-115BC9BD-6BAC-431F-8690-3E6F81235504Q30806903-8B4A7D0C-9362-43FF-AE18-8327BA3F363AQ33235069-5E0E0919-6D9C-4848-8FDF-213FFD437AA1Q33263225-CD940BC8-A0E3-4F3D-A9E2-33F0EEEF269FQ33369720-A6AE6C4F-E8B8-424D-A325-C91BF3F534AEQ33447691-2D25CACC-9B84-4CFC-909B-617FFE2330FEQ33554366-C96CA0A8-BC13-443A-B297-95897D0CB3A6Q33719148-185C874D-C4CF-400C-9A27-DA1887039B87Q34646478-170A94D7-0593-4D9B-950F-BA11057E86E3Q35130646-2A19A134-685A-4A1F-B9D3-E7F6AB1D6792Q35232504-C03B90DB-5ABA-44AE-B5CA-8F6535A4B64BQ35555951-5A322FBC-388E-4450-B503-8CC8619416E0Q35822282-9CE46255-B7EE-45A0-9F46-78E776A184A2Q35976858-EB549417-F13A-4CE7-ABEE-61D85CA6DACDQ35977692-557D5A90-AD6C-490A-AF32-C733306C9E3FQ36083695-73522101-E947-48DA-8791-3B1E87CB2F64Q36136547-E8F14E70-2424-4174-B7A3-FC1C7C9F62D8Q36185372-F6ECCD8E-FD57-49F2-AE06-419DB74772ACQ36200150-816BE980-FBFA-44F5-B865-400985B4F767Q36214907-EF2E9206-7253-4DBD-960D-E2E11CD1BBA1Q36315671-6CEE005B-A5AF-4B7D-B89C-8525D0AB4F05Q36316831-BB77C22A-606E-4228-81F7-A790CD2206DCQ36344276-0A95432E-01CC-4F9D-9F7A-3ED149EA69E8Q36459196-6F218A72-0535-4C3E-B39D-D584D2164DA1Q36505695-79A004D9-C048-4E17-B12C-C9DEF7613C46Q36802689-2C6F5A93-787D-4B00-91F9-3077BDDBAC9FQ36839919-0D8ACF5B-2669-4D19-A6CD-3ACC09BE0101Q36944149-D3AFBB82-CB68-45EA-8CBF-A1B2B4F84E30Q37084645-C947C30A-37F7-42CA-A399-B24922E46E18Q37096500-1AEE059B-ABE4-4339-9E1D-9BC1ACFF373BQ37107517-33F335CA-4AA4-4F2F-BCAA-B06C551C1C9DQ37171165-C169D33D-0FD0-48D9-8170-46ACF2E0B6EAQ37183865-3BB15C88-CF80-4EBD-9C98-EAE196ED01AFQ37188974-A9924BFF-6018-40C3-8BCF-D0435610B8D7Q37241151-59E3CAD3-B76A-4422-A11A-A5CEC19BE1D9Q37246034-267F0FC5-AA54-4086-A9B7-345A03C913EAQ37362252-A7B46171-3504-4C9E-BB4D-AADC18EE2189
P2860
Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo.
description
1992 nî lūn-bûn
@nan
1992 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Conjugates of anticancer agent ...... olecular therapeutics in vivo.
@ast
Conjugates of anticancer agent ...... olecular therapeutics in vivo.
@en
type
label
Conjugates of anticancer agent ...... olecular therapeutics in vivo.
@ast
Conjugates of anticancer agent ...... olecular therapeutics in vivo.
@en
prefLabel
Conjugates of anticancer agent ...... olecular therapeutics in vivo.
@ast
Conjugates of anticancer agent ...... olecular therapeutics in vivo.
@en
P356
P1476
Conjugates of anticancer agent ...... molecular therapeutics in vivo
@en
P2093
P304
P356
10.1021/BC00017A001
P50
P577
1992-09-01T00:00:00Z